Unraveling the role of brain renin angiotensin system in vascular dementia: mechanisms and therapeutic perspectives.

IF 1.6 4区 医学 Q4 NEUROSCIENCES
Kuldeep Kumar, Sonal Aggarwal, Ayush Kandpal, Ramanpreet Kaur, Amteshwar S Jaggi, Harlokesh Narayan Yadav, Dhandeep Singh, Dimple Chopra, Nirmal Singh
{"title":"Unraveling the role of brain renin angiotensin system in vascular dementia: mechanisms and therapeutic perspectives.","authors":"Kuldeep Kumar, Sonal Aggarwal, Ayush Kandpal, Ramanpreet Kaur, Amteshwar S Jaggi, Harlokesh Narayan Yadav, Dhandeep Singh, Dimple Chopra, Nirmal Singh","doi":"10.1007/s00221-025-07072-1","DOIUrl":null,"url":null,"abstract":"<p><p>Dementia is a heterogeneous syndrome characterized by the progressive deterioration of various brain functions, severely impacting cognitive, emotional, and social abilities. According to a World Health Organization (WHO) report, dementia represents a pressing global health concern, with the number of affected individuals projected to triple by 2050. Among its various subtypes, vascular dementia (VD) stands as the second most common form, following Alzheimer's disease (AD). Despite ongoing efforts in drug development, no pharmaceutical entity has yet received approval from the U.S. Food and Drug Administration (FDA) for the treatment of VD. Emerging evidence underscores the critical involvement of the brain's Renin-Angiotensin System (RAS) in the pathogenesis of multiple neurodegenerative disorders, including VD. The intricate roles of RAS components include regulating vascular tone, neuronal growth and survival, regulating cerebral blood flow and endothelial dysfunction, increasing neuroinflammation (by increasing release of IL-1, IL-6, TNF-α, microglial activation), oxidative stress and destruction of BBB integrity, mainly through Angiotensin II type 1 (AT1) and type 2 (AT2) receptors, are of significant interest in the pathophysiology of VD. However, disruptions in these signaling pathways are believed to contribute substantially to the progression of VD. This review addresses the limitations of current therapeutic approaches for VD while emphasizing the untapped potential of RAS-targeted interventions. We systematically explore the neurophysiological mechanisms of brain RAS, their role in promoting neuronal health, and the factors that compromise these pathways, ultimately leading to cognitive decline. By elucidating these mechanisms and challenges, the review offers novel insights into designing innovative RAS-based therapeutic strategies, paving the way for effective clinical management of VD. This work aspires to stimulate further research and development in this underexplored yet promising domain.</p>","PeriodicalId":12268,"journal":{"name":"Experimental Brain Research","volume":"243 5","pages":"130"},"PeriodicalIF":1.6000,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental Brain Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00221-025-07072-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Dementia is a heterogeneous syndrome characterized by the progressive deterioration of various brain functions, severely impacting cognitive, emotional, and social abilities. According to a World Health Organization (WHO) report, dementia represents a pressing global health concern, with the number of affected individuals projected to triple by 2050. Among its various subtypes, vascular dementia (VD) stands as the second most common form, following Alzheimer's disease (AD). Despite ongoing efforts in drug development, no pharmaceutical entity has yet received approval from the U.S. Food and Drug Administration (FDA) for the treatment of VD. Emerging evidence underscores the critical involvement of the brain's Renin-Angiotensin System (RAS) in the pathogenesis of multiple neurodegenerative disorders, including VD. The intricate roles of RAS components include regulating vascular tone, neuronal growth and survival, regulating cerebral blood flow and endothelial dysfunction, increasing neuroinflammation (by increasing release of IL-1, IL-6, TNF-α, microglial activation), oxidative stress and destruction of BBB integrity, mainly through Angiotensin II type 1 (AT1) and type 2 (AT2) receptors, are of significant interest in the pathophysiology of VD. However, disruptions in these signaling pathways are believed to contribute substantially to the progression of VD. This review addresses the limitations of current therapeutic approaches for VD while emphasizing the untapped potential of RAS-targeted interventions. We systematically explore the neurophysiological mechanisms of brain RAS, their role in promoting neuronal health, and the factors that compromise these pathways, ultimately leading to cognitive decline. By elucidating these mechanisms and challenges, the review offers novel insights into designing innovative RAS-based therapeutic strategies, paving the way for effective clinical management of VD. This work aspires to stimulate further research and development in this underexplored yet promising domain.

揭示脑肾素血管紧张素系统在血管性痴呆中的作用:机制和治疗观点。
痴呆症是一种异质性综合征,其特征是各种脑功能的进行性恶化,严重影响认知、情感和社交能力。根据世界卫生组织(世卫组织)的一份报告,痴呆症是一个紧迫的全球健康问题,预计到2050年,受影响的人数将增加两倍。在其各种亚型中,血管性痴呆(VD)是仅次于阿尔茨海默病(AD)的第二常见形式。尽管药物开发正在进行中,但尚未有制药实体获得美国食品和药物管理局(FDA)治疗VD的批准。新出现的证据强调了大脑肾素-血管紧张素系统(RAS)在包括VD在内的多种神经退行性疾病发病机制中的重要作用。RAS组分的复杂作用包括调节血管张力,神经元生长和存活,调节脑血流和内皮功能障碍,增加神经炎症(通过增加IL-1, IL-6, TNF-α的释放,小胶质细胞激活),氧化应激和血脑屏障完整性破坏,主要通过血管紧张素II型1 (AT1)和2型(AT2)受体,在VD的病理生理中具有重要意义。然而,这些信号通路的中断被认为在很大程度上促进了VD的进展。这篇综述指出了目前VD治疗方法的局限性,同时强调了ras靶向干预的未开发潜力。我们系统地探讨了脑RAS的神经生理机制,它们在促进神经元健康中的作用,以及损害这些途径并最终导致认知能力下降的因素。通过阐明这些机制和挑战,该综述为设计创新的基于ras的治疗策略提供了新的见解,为有效的VD临床管理铺平了道路。这项工作旨在刺激这一尚未开发但前景广阔的领域的进一步研究和发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.60
自引率
5.00%
发文量
228
审稿时长
1 months
期刊介绍: Founded in 1966, Experimental Brain Research publishes original contributions on many aspects of experimental research of the central and peripheral nervous system. The focus is on molecular, physiology, behavior, neurochemistry, developmental, cellular and molecular neurobiology, and experimental pathology relevant to general problems of cerebral function. The journal publishes original papers, reviews, and mini-reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信